Updates in HR-MDS and AML

 

ASH 2021 Conference Coverage on VuMedi
J

ASH 2021: Evaluation of IWG 2006 Response Criteria in Patients with HR-MDS Treated With HMA Monotherapy in the 1L Setting

By ASH 2021 Conference Coverage on VuMedi FEATURING Jan Bewersdorf
By ASH 2021 Conference Coverage on VuMedi FEATURING Jan Bewersdorf
115 views
December 23, 2021
0 Comments
Login to view comments. Click here to Login
Updates in HR-MDS and AML
12:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: A Primer on the Biology of MDS

Feat. S. Colla
09:36
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on the Role of Oral HMAs in MDS

Feat. G. Garcia-Manero
15:41
3rd Annual Hematologic Malignancies Symposium

IDH Inhibitors in MDS: Frequency & Prognosis, Mutations, Therapy…

Feat. A. Wei
09:10
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Novel Strategies to Treat Elderly With AML

Feat. T. Kadia
06:04
ASH 2021 Conference Coverage on VuMedi

ASH 2021 Clinical and Pathological Characteristics of Hypocellular M…

Feat. K. Kim
11:04
ASH 2021 Conference Coverage on VuMedi

ASH 2021: Evaluation of IWG 2006 Response Criteria in Patients with …

Feat. J. Bewersdorf
04:45
ASH 2021 Conference Coverage on VuMedi

ASH 2021 on LR-MDS: Factors Predicting Progression to HR-MDS and AML…

Feat. A. Jain
14:11
MDS Foundation

MDS Foundation ASH 2021 Review: When and How Genetic Predisposition …

Feat. L. Malcovati
23:13
MDS Foundation

MDS Foundation ASH 2021 Review: Towards a Genetically Inspired Class…

Feat. E. Bernard
36:53
University of Colorado Division of Hematology

UC Denver ASH Review: Updates on MDS & AML

Feat. C. McMahon
19:55
MDS Foundation

Inflammatory Signaling in the Pathogenesis of MDS

Feat. D. Sallman
25:29
MDS Foundation

Bone Marrow Niche Contributions to MDS Pathogenesis

Feat. H. Medyouf
18:14
Yale Cancer Center

ASH 2021 Highlights for AML

Feat. R. Shallis
21:44
MDS Foundation

MDS Foundation ASH 2021 Review: Can Transplantation Improve Survival…

Feat. G. Mufti
23:56
MDS Foundation

Role of Innate Immune Signaling in MDS

Feat. D. Starczynowski